Spero Therapeutics, Inc.SPRONASDAQ
Loading
Debt to Assets Over TimeElevated
Percentile Rank56
3Y CAGR-3.2%
5Y CAGR-5.7%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-3.2%/yr
Annual compound
5Y CAGR
-5.7%/yr
Consistent
Percentile
P56
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.04 | +27.9% |
| 2023 | 0.03 | -42.9% |
| 2022 | 0.05 | +24.2% |
| 2021 | 0.04 | -16.1% |
| 2020 | 0.05 | -2.3% |
| 2019 | 0.05 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |
| 2015 | 0.00 | - |